Licensing And Distribution Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
Cytomedix, Inc. New – AMENDMENT No. 5 TO LICENSING AND DISTRIBUTION AGREEMENT (October 24th, 2016)

This Amendment No. 5 to LICENSING AND DISTRIBUTION AGREEMENT (this "Amendment No. 5") is dated as of December 31, 2014 by and between Nuo Therapeutics, Inc. (formerly Cytomedix Inc.), a Delaware corporation, with principal office at 207 Perry Parkway, Suite 1, Gaithersburg, MD 20877 ("Nuo" or "Cytomedix") and Millennia Holdings, Inc., a California cooperation, with principal office at 3731 Wilshire Blvd., Suite 900, Los Angeles, CA 90010 ("Millennia"). Capitalized terms used in this Amendment No. 5 shall have the meanings ascribed to them in the Agreement (as defined below).

Fluoropharma Medical, Inc. – Exclusive Licensing and Distribution Agreement (June 9th, 2016)

This Exclusive Licensing and Distribution Agreement ("Agreement") is entered into and effective as of June 03, 2016 ("Effective Date"), by and between FluoroPharma Medical, Inc., a company organized and existing under the laws of Nevada, with its principal place of business located at 8 Hillside Avenue, Suite 207, Montclair, New Jersey, U.S., ("FluoroPharma") and Sinotau USA, Inc. (a subsidiary of Sinotau Pharmaceutical Group, Chinese Name: Bei Jing Xian Tong Guo Ji Yi Yao Ke Ji Gu Fen You Xian Gong Si , i.e. Beijing Xiantong Guoji Yiyao Keji Gufen Youxian Gongsi a company organized and existing under the laws of the People's Republic of China with registered address at Room 6168, #1 Building, #2 Courtyard, Heng Fu Middle Street, Science City, Fengtai District, Beijing China) a company organized under the laws of Delaware, with its principal place of business located at 27 Drydock Avenue, STE 7, Boston, Massachusetts, U.S. ("Sinotau"). FluoroPharma and Sinotau are each referred to her

Fluoropharma Medical, Inc. – Exclusive Licensing and Distribution Agreement (June 9th, 2016)

This Exclusive Licensing and Distribution Agreement ("Agreement") is entered into and effective as of June 03, 2016 ("Effective Date"), by and between FluoroPharma Medical, Inc., a company organized and existing under the laws of Nevada, with its principal place of business located at 8 Hillside Avenue, Suite 207, Montclair, New Jersey, U.S., ("FluoroPharma") and Sinotau USA, Inc. (a subsidiary of Sinotau Pharmaceutical Group, Chinese Name: Bei Jing Xian Tong Guo Ji Yi Yao Ke Ji Gu Fen You Xian Gong Si , i.e. Beijing Xiantong Guoji Yiyao Keji Gufen Youxian Gongsi a company organized and existing under the laws of the People's Republic of China with registered address at Room 6168, #1 Building, #2 Courtyard, Heng Fu Middle Street, Science City, Fengtai District, Beijing China) a company organized under the laws of Delaware, with its principal place of business located at 27 Drydock Avenue, STE 7, Boston, Massachusetts, U.S. ("Sinotau"). FluoroPharma and Sinotau are each referred to he

GeneLink, Inc. – Accounting for Sale of GeneWize and the Licensing and Distribution Agreement and Related Warrants (March 20th, 2012)

In October 2011, GeneLink, Inc. ("the Company", "GeneLink" or "the Seller") entered into certain agreements for the sale of its wholly owned subsidiary, GeneWize Life Sciences, Inc. ("GeneWize") to Capsalus Corp. ("Capsalus" or "the Purchaser"). The transaction involves i) a Stock Purchase Agreement (for the sale of the sub that includes earnout consideration), and an ii) an Interim Management agreement where the Purchaser will receive all profit earned by the GeneWize from October 1, 2011 through the closing of the sale (which is not yet complete and pending shareholder approval at a special meeting).

BIOLASE AND HENRY SCHEIN EXTEND AND AMEND LICENSING AND DISTRIBUTION AGREEMENT BIOLASE Announces Preliminary 2009 Fourth Quarter Results (March 11th, 2010)

IRVINE, CA (March 10, 2010) BIOLASE Technology, Inc. (NASDAQ: BLTI), the worlds leading dental laser company, announced today that it has amended its licensing and distribution agreement with Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of healthcare products and services to office-based practitioners. Within the United Kingdom, Australia, New Zealand, Belgium, Luxembourg, Netherlands, Spain, Germany, Italy, Austria, and North America, all dental sales will continue to be provided exclusively through Henry Schein. The amended agreement provides strong incentives for Henry Schein to focus on its core customer base, and the purchase minimums have been agreed based upon that focus. In addition to the Henry Schein core customer base, BIOLASE will have strong incremental sales and margin incentives to penetrate additional dental offices. The agreement also allows for higher sales organization incentives, unique financing programs and increased luminary and educational events.

Prolink Holdings – Exclusive Licensing and Distribution Agreement (August 14th, 2008)

THIS EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the "Agreement") is entered into on May 12, 2008 (the "Effective Date"), by and between ProLink Solutions, LLC, a Delaware limited liability company ("Supplier"), and SPORT BUSINESS GROUP, a company formed and existing under the laws of France ("Distributor").

Prolink Holdings – Exclusive Licensing and Distribution Agreement (August 14th, 2008)

THIS EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the "Agreement") is entered into on May 14, 2008 (the "Effective Date"), by and between ProLink Solutions, LLC, a Delaware limited liability company ("Supplier"), and Golf Consulting Services (Houservices 24, S.L.) a company formed and existing under the laws of Spain ("Distributor").

LICENSING and DISTRIBUTION AGREEMENT (October 29th, 2007)

Chemische Fabrik KREUSSLER & Co. GmbH with its registered office in 65203 Wiesbaden, Federal Republic of Germany, at Rheingaustrasse 87 - 93 (hereinafter referred to as KREUSSLER)

LICENSING and DISTRIBUTION AGREEMENT (October 22nd, 2007)

Chemische Fabrik KREUSSLER & Co. GmbH with its registered office in 65203 Wiesbaden, Federal Republic of Germany, at Rheingaustrasse 87 - 93 (hereinafter referred to as KREUSSLER)

Auriga Laboratories – Licensing and Distribution Agreement (October 19th, 2007)

Agreement made this 6th day of June, 2007, between Laboratoires Carilene S.A.S a corporation existing under the laws of France, and having its principal place of business at 7, rue du Chant des Oiseaux, 78360 Montesson-France (hereinafter referred to as "Supplier"), and Auriga Laboratories, Inc., existing under the laws of the State of Delaware, U.S.A, having its principal place of business at 2029 Century Park East, Suite 1130, Los Angeles, CA 90067 U.S.A. (hereinafter referred to as "Buyer").

Auriga Laboratories – Contract (October 18th, 2007)

Agreement made this 6th day of June, 2007, between Laboratoires Carilene S.A.S a corporation existing under the laws of France, and having its principal place of business at 7, rue du Chant des Oiseaux, 78360 Montesson-France (hereinafter referred to as "Supplier"), and Auriga Laboratories, Inc., existing under the laws of the State of Delaware, U.S.A, having its principal place of business at 2029 Century Park East, Suite 1130, Los Angeles, CA 90067 U.S.A. (hereinafter referred to as "Buyer").

Auriga Laboratories – CONFIDENTIAL TREATMENT REQUESTED Confidential Portions of This Agreement Which Have Been Redacted Are Marked With Brackets "[***]". The Omitted Material Has Been Filed Separately With the Securities and Exchange Commission. LICENSING AND DISTRIBUTION AGREEMENT (August 9th, 2007)

Agreement made this 6th day of June, 2007, between Laboratoires Carilene S.A.S a corporation existing under the laws of France, and having its principal place of business at 7, rue du Chant des Oiseaux, 78360 Montesson-France (hereinafter referred to as "Supplier"), and Auriga Laboratories, Inc., existing under the laws of the State of Delaware, U.S.A, having its principal place of business at 2029 Century Park East, Suite 1130, Los Angeles, CA 90067 U.S.A. (hereinafter referred to as "Buyer").

Prolink Holdings – Amended and Restated Exclusive Licensing and Distribution Agreement (June 6th, 2007)

THIS AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the Agreement) is entered into on May 8, 2006 (the Effective Date), by and between ProLink Solutions, LLC, a Delaware limited liability company (Supplier), and Elumina Iberica, S.A., a company formed and existing under the laws of Spain (Distributor).

Prolink Holdings – Amended and Restated Exclusive Licensing and Distribution Agreement (June 6th, 2007)

THIS AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the Agreement) is entered into on May 8, 2006 (the Effective Date), by and between ProLink Solutions, LLC, a Delaware limited liability company (Supplier), and Elumina Iberica, S.A., a company formed and existing under the laws of Spain (Distributor).

Prolink Holdings – Second Amended and Restated Exclusive Licensing and Distribution Agreement (June 6th, 2007)

THIS SECOND AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the Agreement) is entered into as of April 9, 2007 (the Effective Date), by and between ProLink Solutions, LLC, a Delaware limited liability company (Supplier), and Elumina Iberica, S.A., a company formed and existing under the laws of Spain (Distributor).

Prolink Holdings – Second Amended and Restated Exclusive Licensing and Distribution Agreement (June 6th, 2007)

THIS SECOND AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the Agreement) is entered into as of April 9, 2007 (the Effective Date), by and between ProLink Solutions, LLC, a Delaware limited liability company (Supplier), and Elumina Iberica, S.A., a company formed and existing under the laws of Spain (Distributor).

Prolink Holdings – Second Amended and Restated Exclusive Licensing and Distribution Agreement (April 13th, 2007)

THIS SECOND AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the Agreement) is entered into as of April 9, 2007 (the Effective Date), by and between ProLink Solutions, LLC, a Delaware limited liability company (Supplier), and Elumina Iberica, S.A., a company formed and existing under the laws of Spain (Distributor).

Sona Mobile Holdings – Amended and Restated Licensing and Distribution Agreement (March 2nd, 2007)

This Amended and Restated Licensing and Distribution Agreement (the Agreement) is effective as of February 28, 2007 (the Effective Date), by and among SHUFFLE MASTER, INC., a Minnesota corporation (Shuffle Master), with an address at 1106 Palms Airport Drive, Las Vegas, Nevada 89119, on the one hand, and SONA MOBILE HOLDINGS CORP., a Delaware corporation (SNMB), and SONA MOBILE, INC., a Delaware corporation (Sona), each with an address at 245 Park Avenue, 39th Floor, New York, New York 10167, on the other hand. As of the Effective Date, this Agreement supersedes and completely amends and restates in its entirety that certain Licensing and Distribution Agreement by and between Shuffle Master and SNMB, dated January 13, 2006.

ADDENDUM #7 TO LICENSING AND DISTRIBUTION AGREEMENTS (2004-2005 and 2005-2007) (June 14th, 2006)

THIS ADDENDUM #7 TO LICENSING AND DISTRIBUTION AGREEMENTS (this Addendum) is dated and effective as of April 1, 2006 (Effective Date), by and between Encore Software, Inc., a Minnesota corporation (Distributor), and Riverdeep Inc., A Limited Liability Company, a Delaware limited liability company (Riverdeep).

Prolink Holdings – Amended and Restated Exclusive Licensing and Distribution Agreement (May 15th, 2006)

THIS AMENDED AND RESTATED EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the Agreement) is entered into on May 8, 2006 (the Effective Date), by and between ProLink Solutions, LLC, a Delaware limited liability company (Supplier), and Elumina Iberica, S.A., a company formed and existing under the laws of Spain (Distributor).

Oscient Pharmaceuticals Corporation – Sublicensing and Distribution Agreement (May 10th, 2006)

SUBLICENSING AND DISTRIBUTION AGREEMENT (the Agreement) entered into by Oscient Pharmaceuticals Corporation (Oscient), represented by Steven M. Rauscher, its President and Chief Executive Officer, a corporation constituted and existing under the laws of the Commonwealth of Massachusetts, United States of America, as party of the first part, Pfizer, S.A. de C.V. (Pfizer Mexico) (both Oscient and Pfizer Mexico may individually be referred to as a Party and collectively as the Parties), represented by Jorge Bracero Cotty, its legal representative, a corporation constituted and existing under the laws of Mexico, in accordance with the following recitals and terms:

Sona Mobile Holdings – Contract (April 21st, 2006)
Sona Mobile Holdings – Contract (April 20th, 2006)
Sona Mobile Holdings – Contract (April 7th, 2006)
Accentia Biopharmaceuticals, Inc. – Licensing and Distribution Agreement (December 29th, 2005)

THIS LICENSING AND DISTRIBUTION AGREEMENT, effective as of November 22, 2005 (Effective Date), between Collegium Pharmaceutical, Inc., a corporation organized and existing under the laws of Delaware, with its principal offices located at 400 Highland Corporate Drive, Cumberland, R.I. 02864 (Collegium), and TEAMM Pharmaceuticals, Inc., an Accentia Biopharmaceuticals Company, a Florida corporation having its principal place of business at 2501 Aerial Center Parkway, Suite 100, Morrisville, NC 27560 (TEAMM).

Prolink Holdings – Exclusive Licensing and Distribution Agreement (December 23rd, 2005)

THIS EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT (the Agreement) is entered into on October 29, 2004, by and between ProLink/ParView, LLC, a Delaware limited liability company (Supplier), and Elumina Iberica SA; a company formed and registered the country of Spain (Distributor).

Bradley Pharmaceuticals – Licensing and Distribution Agreement (December 19th, 2005)

This LICENSING AND DISTRIBUTION AGREEMENT (this Agreement), dated December 13, 2005, by and between BRADLEY PHARMACEUTICALS, INC., a Delaware corporation with an address at 383 Route 46 West, Fairfield, New Jersey (Bradley), and PAR PHARMACEUTICAL, INC., a Delaware corporation with an address at One Ram Ridge Road, Spring Valley, New York (Par).

ADDENDUM #6 TO LICENSING AND DISTRIBUTION AGREEMENTS (2004-2005 and 2005-2007) (November 14th, 2005)

THIS ADDENDUM #6 TO LICENSING AND DISTRIBUTION AGREEMENTS (this Addendum) is dated as of October 6, 2005 and is effective as of June 30, 2005 (Effective Date), by and between ENCORE SOFTWARE, INC., a Minnesota corporation (Distributor), and RIVERDEEP INC., A LIMITED LIABILITY COMPANY, a Delaware limited liability company (Riverdeep), with respect to the following Recitals.

Licensing and Distribution Agreement (March 30th, 2005)

This Licensing and Distribution Agreement is dated effective this 16th day of July, 2004 (the Effective Date) by and between Jones Soda Co., a Washington corporation (Jones) and Target Corporation, a Minnesota corporation (Target).

Licensing and Distribution Agreement (March 30th, 2005)

This Licensing and Distribution Agreement (Agreement) is dated effective this first day of April, 2005 by and between Jones Soda Co., a Washington corporation (Jones) and The Kroger Co., an Ohio corporation, on behalf of itself and its Jackson Ice Cream division (Kroger).

New Mexico Software – Master Software Licensing and Distribution Agreement (November 4th, 2004)

This Agreement (this "Agreement") is made by and between Honeywell Federal Manufacturing and Technologies, LLC, a Delaware corporation with its principal place of business located at 2000 East 95th Street, Kansas City, MO 64131-6159 ("Licensee"), and New Mexico Software (NMS), a Delaware corporation with its principal place of business located at 5041 Indian School Road NE, Albuquerque, NM 87110 ("Licensor").